Determination of citalopram and escitalopram together with their active main metabolites desmethyl(es-)citalopram in human serum by column-switching high performance liquid chromatography (HPLC) and spectrophotometric detection

被引:64
作者
Greiner, Christine [1 ]
Hiemke, Christoph [1 ]
Bader, Wolfgang [1 ]
Haen, Ekkehard [1 ]
机构
[1] Univ Regensburg, Dept Psychiat Psychosomat & Psychotherapy, D-93053 Regensburg, Germany
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2007年 / 848卷 / 02期
关键词
citalopram; escitalopram; quantitative analysis; HPLC column-switching; TDM;
D O I
10.1016/j.jchromb.2006.10.058
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We established a method for automated quantitative analysis of (es-)citalopram and desmethyl(es-)citalopram in serum using column-switching high performance liquid chromatography (HPLC). For sample clean-up serum was injected onto a LiChrospher CN 20 mu m precolumn using 8% acetonitrile in deionized water. Drugs were eluted by back-flush flow onto the analytical column (LiChrospher CN 5 mu m) at a flow rate of 1.5 ml/min with phosphate buffer 8 mmol/l pH 6.4/acetonitrile (50/50, v/v). Haloperidol was used as internal standard. Analytes were detected by ultraviolet spectrophotometry at 210 nm. Detection limit of (es-)citalopram was 6 ng/ml. The method was found to be suitable for therapeutic drug monitoring of patients treated with citalopram or escitalopram. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:391 / 394
页数:4
相关论文
共 13 条
[1]   High-performance liquid chromatography method for analyzing citalopram and desmethylcitalopram from human serum [J].
Akerman, KK ;
Jolkkonen, J ;
Huttunen, H ;
Penttila, I .
THERAPEUTIC DRUG MONITORING, 1998, 20 (01) :25-29
[2]  
[Anonymous], 2006, **DROPPED REF**
[3]   The AGNP-TDM expert group consensus guidelines:: Therapeutic Drug Monitoring in psychiatry [J].
Baumann, P ;
Hiemke, C ;
Ulrich, S ;
Eckermann, G ;
Gaertner, I ;
Gerlach, M ;
Kuss, HJ ;
Laux, G ;
Müller-Oerlinghausen, B ;
Rao, ML ;
Riederer, P ;
Zernig, G .
PHARMACOPSYCHIATRY, 2004, 37 (06) :243-265
[4]   RELATIONSHIP BETWEEN CLINICAL EFFECTS, SERUM DRUG CONCENTRATION AND SEROTONIN UPTAKE INHIBITION IN DEPRESSED-PATIENTS TREATED WITH CITALOPRAM - A DOUBLE-BLIND COMPARISON OF 3 DOSE LEVELS [J].
BJERKENSTEDT, L ;
FLYCKT, L ;
OVERO, KF ;
LINGJAERDE, O .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (05) :553-557
[5]   A high-performance liquid chromatography method with photodiode-array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs [J].
Duverneuil, C ;
de la Grandmaison, GL ;
de Mazancourt, P ;
Alvarez, JC .
THERAPEUTIC DRUG MONITORING, 2003, 25 (05) :565-573
[6]  
IFPMA, 1995, FED REGISTER, V60, P11260
[7]   Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection [J].
Kristoffersen, L ;
Bugge, A ;
Lundanes, E ;
Slordal, L .
JOURNAL OF CHROMATOGRAPHY B, 1999, 734 (02) :229-246
[8]   Rapid determination of citalopram in human plasma by high-performance liquid chromatography [J].
Macek, J ;
Ptácek, P ;
Klíma, J .
JOURNAL OF CHROMATOGRAPHY B, 2001, 755 (1-2) :279-285
[9]  
Popik P., 1999, J CLIN PSYCHOPHARM, V19, P4
[10]   Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting [J].
Reis, M ;
Olsson, G ;
Carlsson, B ;
Lundmark, J ;
Dahl, ML ;
Wålinder, J ;
Ahlner, J ;
Bengtsson, F .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (04) :406-413